Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Clinical trial NCT07392541 · RECRUITING
Trial details
- NCT number
- NCT07392541
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2028-01-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.